New hope for pancreatic cancer: drug combo trial launches
Disease control
Not yet recruiting
This study tests a new combination treatment for people with metastatic pancreatic cancer that has spread to other parts of the body. The treatment combines a drug called rimegepant with standard chemotherapy (AG). The goal is to see if this combination can slow down the cancer's…
Phase: PHASE1, PHASE2 • Sponsor: Xiuchao Wang • Aim: Disease control
Last updated May 19, 2026 11:59 UTC